GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, HCAR2, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
7.94698 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, HCAR2, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
7.94698 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, EPHX2, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD17B1, HSD17B2, HTR1A, HTR2B, HTR7, KDR, MET, PPARA, SRC, TNKS, TNKS2, XDH |
7.9297 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2, FABP3, FABP4, FLT3, HSD17B2, HTR2B, HTR5A, IGF1R, KDR, MMP2, MMP9, PPARA, RORC, SRC, TYR |
7.39513 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, MET, PPARA |
7.23674 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.8821 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP3, HSD17B2, HTR5A, IGF1R, MMP2, MMP9, PPARA, RORC, SRC, TYR |
6.84213 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.50246 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP3, FABP4, FLT3, HSD17B2, HTR5A, IGF1R, KDR, MMP2, PPARA, RORC, SRC, TYR |
6.50246 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, FUT7, HTR2B, PIM1, PPARA, TYR, XDH |
6.27521 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, HTR2B, HTR5A, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPRS, RORC, SRC, TNKS2, TYR |
5.99769 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC |
5.89449 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.88601 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, HTR5A, RORC, SRC, TYR |
5.59729 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FLT3, HTR5A, RORC, SRC, TYR |
5.5737 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
5.38291 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, EPHX2, F3, FABP3, FABP4, FLT3, HCAR2, HTR1A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
5.33536 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
5.28722 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2, F3, FABP4, HSD17B2, HTR1A, HTR2B, HTR7, IGF1R, MET, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS2, TYR |
5.23499 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.23499 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.23499 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TYR, XDH |
5.21243 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F3, FLT3, HTR2B, HTR6, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
5.21243 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, F3, FABP3, FLT3, HCAR2, HTR1A, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
5.1215 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
5.08291 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, DRD1, DRD2, HCAR2, HTR2B, KDR, SRC, TNKS, TNKS2 |
5.03012 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
5.01314 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, EPHX2, FABP3, FABP4, FUT7, MET, PPARA |
4.97816 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EPHX2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, XDH |
4.86144 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
4.85648 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, EPHX2, KDR, SRC |
4.83432 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, HTR1A, TYR |
4.71323 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CSNK2A1, DRD2, F3, FLT3, HTR1A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1 |
4.69506 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
4.68848 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD17B1, HSD17B2 |
4.61448 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EPHX2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PTPN1, PTPRS, SRC, TNKS, XDH |
4.57489 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD11B1, HSD17B1, HSD17B2 |
4.44218 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2, F3, FABP3, FABP4, FLT3, HSD17B2, HTR1A, HTR2B, HTR5A, IGF1R, KDR, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SRC, TYR |
4.44218 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.38433 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.38433 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, HTR1A, TYR |
4.29349 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, AXL, BCL2, CYP1B1, DRD2, F3, FLT3, HTR2B, HTR6, KDR, MET, PTPN1, SRC, XDH |
4.2166 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, ALPL, AXL, BCL2, CA2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FLT3, HSD11B1, HSD17B2, HTR5A, KDR, MMP9, PIM1, PPARA, PTPRS, RORC, SRC, TYR |
4.21009 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F3, FABP4, FLT3, HTR2B, HTR6, KDR, MET, MMP12, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
4.19815 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, FABP3, FLT3, HTR5A, IGF1R, MMP2, PPARA, SRC |
4.19815 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, F3, FABP3, FLT3, HTR1A, HTR2B, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SRC, XDH |
4.16236 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, XDH |
4.1484 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, HTR2B, KDR, SRC |
4.14161 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP2, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TYR, XDH |
4.11394 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, HTR2B, KDR, SRC |
4.07764 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, PPARA |
4.07764 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, HCAR2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SRC |
4.07241 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, HCAR2, HSD11B1, HSD17B1, HSD17B2, HTR1A |
3.98297 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD11B1, HSD17B2, KDR, PPARA, PTPRS, SRC, TYR |
3.98297 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, XDH |
3.96928 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
3.95719 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, HCAR2, TNKS, TNKS2 |
3.92244 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
3.8991 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, EPHX2 |
3.8991 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, HTR5A, PPARA, SRC |
3.80035 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
3.79976 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC, TNKS |
3.77378 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA |
3.76565 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.70687 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.70515 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.63797 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F3, FLT3, HTR2B, HTR6, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
3.59738 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
3.55873 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, HTR1A |
3.51281 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, RORC, SRC |
3.51199 |
[BP] GO:0007187 |
None
|
CHRM2, DRD1, DRD2, HTR1A, HTR5A, HTR6, HTR7 |
3.50604 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, EPHX2, FABP3, FLT3, HCAR2, HTR2B, PPARA, RORC, SRC |
3.49094 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, HCAR2, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, XDH |
3.44989 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC |
3.43157 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.33792 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, HTR7, PPARA, RORC, SRC |
3.31895 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FABP4, FLT3, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
3.30572 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, RORC, SRC |
3.26996 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.1984 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.1984 |
[BP] GO:0007193 |
None
|
CHRM2, DRD2, HTR1A, HTR5A, HTR7 |
3.16332 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
3.13962 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CYP1A1, FLT3, HTR1A, MET, PIM1, SRC, TYR |
3.1259 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2 |
3.12442 |
[BP] GO:0032845 |
None
|
BCL2, DRD2, HTR2B, SRC, TNKS, TNKS2 |
3.03575 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9 |
3.00843 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ALOX15, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, HCAR2, HTR1A, HTR2B, MMP12, MMP9, PPARA, PTPN1, SRC |
2.93985 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, SRC, TNKS |
2.88596 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.87608 |
[BP] GO:0003018 |
None
|
DRD1, EPHX2, HTR1A, HTR2B, HTR7, SRC |
2.87325 |
[BP] GO:0007188 |
None
|
CHRM2, DRD1, DRD2, HTR1A, HTR5A, HTR7 |
2.8607 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC |
2.82169 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2B, SRC |
2.82169 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HTR2B, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TYR, XDH |
2.78772 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, EPHX2, FABP3, FABP4, FLT3, HTR2B, MET, SRC |
2.76369 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, BCL2, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, HTR1A, HTR2B, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TYR, XDH |
2.74209 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DRD1, DRD2, F3, FLT3, FUT7, HTR1A, HTR2B, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
2.71105 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, PPARA |
2.65839 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR2B, HTR7 |
2.65839 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EPHX2 |
2.63277 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.63277 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EPHX2, F3, FABP3, FLT3, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.62356 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, EPHX2, F3, FLT3, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.619 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
2.57226 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PTPN1, RORC, SRC |
2.56988 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.56988 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F3, FLT3, HTR2B, HTR6, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
2.56988 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.55044 |
[BP] GO:0030334 |
regulation of cell migration
|
BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC |
2.54895 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.54587 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.54587 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.52808 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.5139 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.51046 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, FABP4, FUT7, MMP12, MMP2, MMP9, SRC, XDH |
2.50436 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, BCL2, CDC25B, DRD1, DRD2, FABP3, FLT3, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
2.50436 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, BCL2, CDC25B, DRD1, DRD2, FABP3, FLT3, HTR2B, KDR, MMP9, PTPN1, SRC, XDH |
2.50436 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.48611 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, DRD1, DRD2, EPHX2, FABP3, FABP4, HTR2B, MET |
2.48611 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.46577 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.46577 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EPHX2, RORC |
2.46577 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, AXL, BCL2, CA1, CA2, CHRM2, CSNK2A1, CYP1B1, DRD1, DRD2, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2 |
2.46188 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, F3, FLT3, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.44417 |
[BP] GO:1900673 |
olefin metabolic process
|
CYP1A1, EPHX2 |
2.44342 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.44342 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, HCAR2, HTR2B, MMP12, SRC |
2.42245 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.35984 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2B, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.35872 |
[BP] GO:2000145 |
regulation of cell motility
|
BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC |
2.35409 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2B, PPARA, SRC |
2.33302 |
[BP] GO:0003013 |
None
|
DRD1, EPHX2, HTR1A, HTR2B, HTR7, SRC |
2.32898 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.32898 |
[BP] GO:0097746 |
None
|
DRD1, EPHX2, HTR1A, HTR2B, HTR7 |
2.32614 |
[BP] GO:0035296 |
None
|
DRD1, EPHX2, HTR1A, HTR2B, HTR7 |
2.32614 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP12, MMP9, SRC |
2.31439 |
[BP] GO:0044092 |
negative regulation of molecular function
|
AURKB, CSNK2A1, CYP1B1, DRD2, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
2.30019 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
2.30019 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD17B1, HSD17B2 |
2.28899 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, HTR2B, MMP2, PPARA, SRC, TYR |
2.2851 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.28362 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, F3, MET, SRC, XDH |
2.28092 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, BCL2, CDC25B, DRD1, DRD2, FABP3, FABP4, FLT3, HTR2B, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.27209 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27209 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, AURKB, BCL2, CDC25B, DRD1, DRD2, F3, FABP3, FLT3, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.24741 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, BCL2, CDC25B, DRD1, DRD2, FABP3, FABP4, FLT3, HTR2B, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.23484 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, EPHX2, FABP3, PIM1, PPARA, TYR |
2.23368 |
[BP] GO:0050880 |
None
|
DRD1, EPHX2, HTR1A, HTR2B, HTR7 |
2.2318 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.2265 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MET, MMP12, MMP9, SRC |
2.22592 |
[BP] GO:0035150 |
None
|
DRD1, EPHX2, HTR1A, HTR2B, HTR7 |
2.22294 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2B, IGF1R, KDR, MMP9, PTPN1, SRC, XDH |
2.2176 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.2176 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.2176 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.20835 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, SRC, TNKS |
2.1682 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AXL, BCL2, CBR1, CDC25B, CYP1A1, DRD1, DRD2, FABP4, FLT3, FUT7, HTR2B, KDR, MET, MMP2, MMP9, PTPRS, RORC, SRC |
2.16097 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2, F3, FABP3, FABP4, FLT3, FUT7, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
2.15059 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.14595 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2B, SRC |
2.1339 |
[BP] GO:0040012 |
regulation of locomotion
|
BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC |
2.12597 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.11957 |
[BP] GO:0051270 |
regulation of cellular component movement
|
BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC |
2.11711 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.10833 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, HCAR2, HTR2B, MMP12, SRC |
2.08334 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC, TNKS |
2.0807 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.04735 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.04527 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.0386 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.0386 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.0386 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, MMP12, MMP9, SRC |
2.03646 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, DRD1, FLT3, RORC, SRC |
2.03646 |
[BP] GO:0042310 |
None
|
HTR1A, HTR2B, HTR7 |
2.03646 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
2.03646 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.03445 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, KDR, MET, MMP9, SRC, TNKS, TNKS2 |
2.02393 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, HCAR2, HTR2B, MMP12, SRC |
2.00613 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, CYP19A1, DRD2, F3, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PTPN1, PTPRS, SRC, XDH |
2.00613 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A |
2.00447 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A |
2.00447 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, F3, FLT3, FUT7, HCAR2, HSD11B1, HSD17B2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR |
3.42837 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ALOX15, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, DRD1, DRD2, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, PTPRS, SRC |
3.28453 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
AXL, CA4, CHRM2, DRD1, DRD2, F3, FLT3, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPRS |
2.99728 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ALOX15, AXL, CA2, CA4, CA9, CHRM2, DRD1, DRD2, F3, FLT3, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPRS, SRC |
2.50508 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ALOX15, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, F3, FLT3, FUT7, HCAR2, HSD11B1, HSD17B2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPN1, PTPRS, SRC, TYR |
2.27368 |
[CC] GO:0005887 |
integral component of plasma membrane
|
AXL, CHRM2, DRD1, DRD2, FLT3, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PTPRS |
2.14595 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2, F3, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
9.93078 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.92829 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
8.76779 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX2, F3, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIM1, PTPN1, PTPRS, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
8.42731 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.31559 |
[MF] GO:0008227 |
None
|
CHRM2, DRD2, HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
6.26074 |
[MF] GO:0030594 |
None
|
CHRM2, DRD1, DRD2, HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.82192 |
[MF] GO:0099528 |
None
|
CHRM2, HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.78004 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR2B, HTR5A, HTR7 |
5.63014 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EPHX2, HTR1A, HTR2B, HTR5A, HTR7, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, TNKS2, TYR, XDH |
5.63014 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.59729 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.23499 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
5.23499 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2B, HTR5A, HTR7 |
4.88912 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2B, HTR5A, HTR7 |
4.88912 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
4.85648 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MET, PIM1, PPARA, SRC |
4.44218 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD17B1, HSD17B2, XDH |
4.195 |
[MF] GO:0038023 |
signaling receptor activity
|
AXL, CHRM2, DRD1, DRD2, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC |
3.8991 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2B, HTR5A, HTR7 |
3.84312 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.81894 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.76565 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TNKS |
3.70515 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.57341 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.52792 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.49472 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD17B1, HSD17B2 |
3.44132 |
[MF] GO:0004872 |
receptor activity
|
AXL, CHRM2, DRD1, DRD2, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC |
3.30052 |
[MF] GO:0060089 |
molecular transducer activity
|
AXL, CHRM2, DRD1, DRD2, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC |
3.14225 |
[MF] GO:0099600 |
transmembrane receptor activity
|
AXL, CHRM2, DRD1, DRD2, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
3.14225 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
AXL, CHRM2, DRD1, DRD2, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET |
3.14225 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.10659 |
[MF] GO:0004871 |
signal transducer activity
|
AXL, CHRM2, DRD1, DRD2, F3, FLT3, HCAR2, HTR1A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, RORC |
2.81225 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.76138 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.75849 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.55701 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EPHX2, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, TNKS2, TYR, XDH |
2.34254 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.27942 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.16097 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.10833 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2 |
2.03646 |